ARCHIVES

Clinical Trials: Phase I Trial of Karenitecin Begins, BioNumerik Says

This article is from The Cancer Letter archive.

Vol. 25 No. 09 | March 5, 1999

Download PDF Visit The Full Archive

Related Articles

NCCS Networker Volume 2 Issue 4, Fall 1988

September 13, 1988

Report Urges Changes To Cut Activation Times For NCI Phase III Trials.

April 9, 2010

Research: No Increase in Cancer Deaths Found at Three Mile Island

May 5, 2000

Regulatory Agencies: FDA To Increase Fees For Mammography Facility Inspections

January 30, 1998

City of Hope Selects Michael Friedman As President, CEO

May 16, 2003

Cancer Patient Lobby Outlines Agenda For FDA Reform, Seeks Role In Discussion

June 23, 1995